Airway remodeling and lack of bronchodilator response in steroid-resistant asthma.

[1]  S. Wenzel.  Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[2]  S. Holgate,et al.  The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.

[3]  L. Boulet,et al.  Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. , 2006, Chest.

[4]  Richard J Martin,et al.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. , 2006, American journal of respiratory and critical care medicine.

[5]  M. Kraft,et al.  Airway remodeling from bench to bedside: current perspectives. , 2006, Clinics in chest medicine.

[6]  P. Howarth,et al.  Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. , 2006, The Journal of allergy and clinical immunology.

[7]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[8]  G. Mattioli,et al.  IL-8 and airway neutrophilia in children with gastroesophageal reflux and asthma-like symptoms. , 2006, Respiratory medicine.

[9]  A. Vignola,et al.  Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent‐mild asthma , 2005, Allergy.

[10]  Q. Hamid,et al.  Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. , 2005, The Journal of allergy and clinical immunology.

[11]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[12]  S. Peters,et al.  Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. , 2005, The Journal of allergy and clinical immunology.

[13]  C. Salome,et al.  A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. , 2005, Chest.

[14]  S. Fukuhara,et al.  Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma , 2005, Thorax.

[15]  M. Hoshino.  Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling , 2004, Clinical reviews in allergy & immunology.

[16]  S. Wenzel,et al.  Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. , 2003, The Journal of allergy and clinical immunology.

[17]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[18]  K. Chung,et al.  Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. , 2002, Chest.

[19]  P. Barnes,et al.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.

[20]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[21]  William M Vollmer,et al.  Association of asthma control with health care utilization: a prospective evaluation. , 2002, American journal of respiratory and critical care medicine.

[22]  M. Zacharisen,et al.  National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002. , 2002, The Journal of allergy and clinical immunology.

[23]  N. Aoike,et al.  Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  W. Busse,et al.  Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.

[25]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[26]  Bousquet,et al.  VEGF levels in asthmatic airways do not correlate with plasma extravasation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  M. Hoshino,et al.  Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.

[28]  J. Lafitte,et al.  Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. , 1999, American journal of respiratory and critical care medicine.

[29]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[30]  S. Szefler,et al.  Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. , 1998, The Journal of allergy and clinical immunology.

[31]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[32]  T. Stephenson,et al.  Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. , 1997, Journal of immunology.

[33]  S. Szefler,et al.  Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. , 1994, The Journal of clinical investigation.

[34]  W. Busse,et al.  Steroid-resistant asthma. , 1993, The Journal of allergy and clinical immunology.

[35]  P. Selecky,et al.  Position Paper on Guidelines for Fiberoptic Bronchoscopy in Adults , 1987 .

[36]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[37]  Guidelines for fiberoptic bronchoscopy in adults. American Thoracic Society. Medical Section of the American Lung Association. , 1987, The American review of respiratory disease.